Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
47398 participants
INTERVENTIONAL
2021-10-01
2022-04-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
This study has two primary objectives are: to evaluate the effects of an information nudge reminding on the importance of diagnosing and treating health problems and to evaluate the effects of additionally providing information on the fact that primary care nurse visits have become exempt from copayments. Main outcomes include the number of primary care nurse visits and general practitioner (GP) visits in a six-month follow-up.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Reminders on Adherence
NCT02411006
Evidence-Based Medicine Electronic Decision Support Study
NCT00915304
Preserving ACTs - Text Reminders to Increase Adherence to ACT Treatment
NCT01722734
Email-based Reminders Promoting Recommended Pediatric Preventative Visits
NCT05317884
Information Provision and Consistency Framing to Increase COVID-19 Booster Uptake
NCT05586178
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Basic letter
This reminder states that if healthcare is not consumed at the right time, health may deteriorate and diagnoses and treatment may be delayed.
Reminder (information letter)
Reminders
Co-pay
This reminder states that if healthcare is not consumed at the right time, health may deteriorate and diagnoses and treatment may be delayed AND informs recipients about a new law that abolished all co-payments for all primary care nurse visits in Finland.
Reminder (information letter)
Reminders
GP-Co-pay
This reminder states that if healthcare is not consumed at the right time, health may deteriorate and diagnoses and treatment may be delayed AND informs recipients about a new law that abolished all co-payments for all primary care nurse visits in Finland, AND informs recipients that the new law did not abolish co-payments related to general practitioner visits.
Reminder (information letter)
Reminders
Control treatment
There is no intervention in the control treatment. The entire population aged 55 and above in the treatment regions will serve as a control group.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Reminder (information letter)
Reminders
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Born in 1966 or earlier (aged 55 or more at the end of 2021).
* Living in a household with a maximum of three individuals aged 55 or above.
Exclusion Criteria
55 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Finnish Institute for Health and Welfare
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Lauri Sääksvuori
Associate professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Lauri Sääksvuori, PhD
Role: PRINCIPAL_INVESTIGATOR
Finnish Institute for Health and Welfare and University of Turku
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Finnish Institute for Health and Welfare
Helsinki, , Finland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
THL/3181/6.02.01/2021
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.